289 related articles for article (PubMed ID: 15615643)
1. Transgenic animal models of tauopathies.
Lee VM; Kenyon TK; Trojanowski JQ
Biochim Biophys Acta; 2005 Jan; 1739(2-3):251-9. PubMed ID: 15615643
[TBL] [Abstract][Full Text] [Related]
2. Studying tauopathies in Drosophila: A fruitful model.
Sun M; Chen L
Exp Neurol; 2015 Dec; 274(Pt A):52-7. PubMed ID: 25862286
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
5. Mutations causing neurodegenerative tauopathies.
Goedert M; Jakes R
Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
[TBL] [Abstract][Full Text] [Related]
6. Analysis of tauopathies with transgenic mice.
Hutton M; Lewis J; Dickson D; Yen SH; McGowan E
Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522
[TBL] [Abstract][Full Text] [Related]
7. Transgenic Drosophila models of Alzheimer's disease and tauopathies.
Iijima-Ando K; Iijima K
Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412
[TBL] [Abstract][Full Text] [Related]
8. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
Paquet D; Schmid B; Haass C
Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
[TBL] [Abstract][Full Text] [Related]
9. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
10. [Animal models of tauopathies].
Higuchi M
Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
[TBL] [Abstract][Full Text] [Related]
11. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
[TBL] [Abstract][Full Text] [Related]
12. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
13. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.
Chen F; David D; Ferrari A; Götz J
Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
[TBL] [Abstract][Full Text] [Related]
16. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation.
Chanu SI; Sarkar S
Mol Neurobiol; 2017 May; 54(4):2706-2719. PubMed ID: 27000837
[TBL] [Abstract][Full Text] [Related]
17. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
18. Frontotemporal dementia and tauopathy.
Yoshiyama Y; Lee VM; Trojanowski JQ
Curr Neurol Neurosci Rep; 2001 Sep; 1(5):413-21. PubMed ID: 11898551
[TBL] [Abstract][Full Text] [Related]
19. SJLB mice develop tauopathy-induced parkinsonism.
Takenokuchi M; Kadoyama K; Chiba S; Sumida M; Matsuyama S; Saigo K; Taniguchi T
Neurosci Lett; 2010 Apr; 473(3):182-5. PubMed ID: 20178834
[TBL] [Abstract][Full Text] [Related]
20. Neurodegenerative tauopathies.
Lee VM; Goedert M; Trojanowski JQ
Annu Rev Neurosci; 2001; 24():1121-59. PubMed ID: 11520930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]